Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-5 of 5 (Search time: 0.006 seconds).
Issue DateTitleAuthor(s)
2021IMpower133: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage Small-Cell Lung CancerRECK, M.; HORN, L.; MOK, T. S. K.; MANSFIELD, A.; BOER, R. De; LOSONCZY, G.; SUGAWARA, S.; DZIADZIUSZKO, R.; KRZAKOWSKI, M.; SMOLIN, A.; HOCHMAIR, M.; GARASSINO, M.; CASTRO, G.; BISCHOFF, H.; CARDONA, A.; MORRIS, S.; LIU, S.
2021Pleckstrin Homology-Like (PHLDA) Domain Family Members Immunoexpression as Prognostic Marker in Lung Cancer and MesotheliomaBALDAVIRA, C. Machado; PRIETO, T.; BALANCIN, M.; EHER, E.; FERNEZLIAN, S.; SOUZA, P.; NAGAI, M.; CAPELOZZI, V.
2021KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+Locally Advanced/Metastatic NSCLCCHO, B. C.; WU, Y.; LOPES, G.; KUDABA, I.; KOWALSKI, D. M.; TURNA, H. Z.; CASTRO JR., G. De; CAGLEVIC, C.; ZHANG, L.; KARASZEWSKA, B.; LAKTIONOV, K. K.; SRIMUNINNIMIT, V.; BONDARENKO, I.; KUBOTA, K.; YIN, L.; LIN, J.; SOUZA, F.; MOK, T. S. K.
2021Development of Machine Learning Model to Estimate Overall Survival in Patients with Advanced NSCLC and ECOG-PS > 1CUNHA, M.; BORGES, A. P.; CARVALHO, V.; FUJITA, A.; CASTRO JR., G. D.
2021Phase 3 Study of First-Line Pembrolizumab +/- Vibostolimab (anti-TIGIT) in Patients With PD-L1-Positive Metastatic NSCLCHELLMANN, M. D.; CHO, B. C.; JUERGENS, R.; CHENG, Y.; CASTRO JR., G. De; ERMAN, M.; BAUMAN, J. R.; TAKAHASHI, T.; SCHWARZENBERGER, P.; ZHANG, P.; PIETANZA, M. C.; YANG, J. C.
  • previous
  • 1
  • next